700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02520

Synthetic patientMETA-24 · Day 170 · 75+ · M · baseline S06Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S06
  2. Day 16 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 16.

Primary contributors, last 14 days
  • Treatment adherence-5
  • GI instability+2
  • Toxicity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    87 min
    improving · +8.5 vs previous 14 d
    Sleep duration
    Wearable
    7.1 h
    stable · +0.2 vs previous 14 d
    Energy level
    Daily log
    6.4/10
    improving · +0.9 vs previous 14 d
    Steps
    Wearable
    8,686
    improving · +699 vs previous 14 d
    GI burden
    Companion
    13.5/100
    improving · -7.5 vs previous 14 d
    Adherence
    Companion
    87.3 %
    worsening · -4.0 vs previous 14 d
    Sleep quality
    Wearable
    53.5/100
    improving · +6.7 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    133 mg/dL
    stable · -2.6 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading drifting · 89 from the failing basin, 6 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +10.9
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein
      supporter · GI -5.7 next day
    Main detractors to watch
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • IL6 high-expression variant
      hidden · steering -7.3
    • Ultra-processed food
      perturbation · steering -6
    • Antibiotic course
      perturbation · steering -4.7
    • Ultra-processed food
      detractor · GI +3.4 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5.7supporter · 95%
    • Ultra-processed food
      +3.4detractor · 90%
    • Insoluble fibre
      -2.1no signal · 41%
    • Histamine load
      +1.7no signal · 38%
    • Simple carbohydrates
      +1.6no signal · 31%
    • Dietary fat load
      -1.2no signal · 22%
    • Alcohol
      +1.1no signal · 23%
    • Caffeine
      -0.7no signal · 18%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling ↑45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 3.8 · butyrate capacity 59/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    51 ms
    Sleep
    6.4 h
    Steps
    8,524
    Resting HR
    61 bpm
    Daily log: GI score 14, nutritional resilience 69, adherence 87.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0206844%S14NP-02improved83
    P-0269043%S02ME-01improved73
    P-0246239%S12DT-01improved65
    P-0266739%S08HY-01improved77
    P-0212738%S11SC-12improved73
    P-0241538%S17GI-04improved86
    P-0244138%S11SC-12improved67
    P-0246437%S18ME-01improved68
    P-0248637%S10ME-01improved86
    P-0262037%S01HY-01improved64
    P-0263037%S17NP-02improved76
    P-0245036%S12NP-02improved92